1. Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 study. (January 2022) Authors: Vermeire, Severine; Lakatos, Peter L; Ritter, Timothy; Hanauer, Stephen; Bressler, Brian; Khanna, Reena; Isaacs, Kim; Shah, Saumin; Kadva, Alysha; Tyrrell, Helen; Oh, Young S; Tole, Swati; Chai, Akiko; Pulley, Jennifer; Eden, Christopher; Zhang, Wenhui; Feagan, Brian G; Abraham, Philip; Acir Crip... Journal: Lancet gastroenterology and hepatology Issue: Volume 7:Number 1(2022) Page Start: 28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. In vitro quantitative and relative gene expression analysis of pancreatic transcription factors Pdx‐1, Ngn‐3, Isl‐1, Pax‐4, Pax‐6 and Nkx‐6.1 in trans‐differentiated human hepatic progenitors. Issue 5 (29th January 2014) Authors: Vishwakarma, Sandeep Kumar; Rahamathulla, Syed; Bardia, Avinash; Tiwari, Santosh K; Srinivas, Gunda; Raj, Avinash; Tripura, Chaturvedula; Sandhya, Annamaneni; Habeeb, Mohammed Aejaz; Khan, Aleem A; Pande, Gopal; Reddy, K Pratap; Reddy, P Yugandhar Journal: Journal of diabetes investigation Issue: Volume 5:Issue 5(2014:Oct.) Page Start: 492 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗